| # | Security | Value | Shares | % Port | Change | Δ Shares |
|---|---|---|---|---|---|---|
| 1 | ASCENDIS PHARMA A/S - ADR SPONSORED ADR | $2.4B | 10.28M | 24.9% | —HELD | 0 |
| 2 | VAXCYTE INC COMMON STOCK | $666.8M | 11.47M | 7.1% | ADDED | +750.0K |
| 3 | RHYTHM PHARMACEUTICALS INC COMMON STOCK | $579.8M | 6.67M | 6.1% | —HELD | 0 |
| 4 | TYRA BIOSCIENCES INC COMMON STOCK | $467.2M | 12.20M | 5.0% | —HELD | 0 |
| 5 | SIONNA THERAPEUTICS INC COMMON STOCK | $397.1M | 9.91M | 4.2% | —HELD | 0 |
| 6 | EDGEWISE THERAPEUTICS INC COMMON STOCK | $328.5M | 10.43M | 3.5% | —HELD | 0 |
| 7 | NEWAMSTERDAM PHARMA CO NV COMMON STOCK | $305.7M | 9.55M | 3.2% | —HELD | 0 |
| 8 | NUVALENT INC-A COMMON STOCK | $259.6M | 2.53M | 2.8% | ADDED | +654.1K |
| 9 | DIANTHUS THERAPEUTICS INC COMMON STOCK | $219.2M | 2.61M | 2.3% | ADDED | +1.00M |
| 10 | MINERALYS THERAPEUTICS INC COMMON STOCK | $208.4M | 7.69M | 2.2% | ADDED | +369.0K |
| 11 | SPYGLASS PHARMA INC COMMON STOCK | $207.8M | 8.02M | 2.2% | NEW | — |
| 12 | WAVE LIFE SCIENCES LTD COMMON STOCK | $195.6M | 26.98M | 2.1% | ADDED | +8.77M |
| 13 | SEPTERNA INC COMMON STOCK | $168.1M | 7.00M | 1.8% | —HELD | 0 |
| 14 | DISC MEDICINE INC COMMON STOCK | $156.7M | 2.45M | 1.7% | ADDED | +474.1K |
| 15 | JANUX THERAPEUTICS INC COMMON STOCK | $155.5M | 11.19M | 1.6% | —HELD | 0 |
| 16 | BIOCRYST PHARMACEUTICALS INC COMMON STOCK | $150.7M | 15.83M | 1.6% | —HELD | 0 |
| 17 | BICARA THERAPEUTICS INC COMMON STOCK | $144.3M | 7.26M | 1.5% | ADDED | +300.0K |
| 18 | PRAXIS PRECISION MEDICINES I COMMON STOCK | $120.4M | 373.8K | 1.3% | —HELD | 0 |
| 19 | GH RESEARCH PLC COMMON STOCK | $107.9M | 7.68M | 1.1% | —HELD | 0 |
| 20 | ZAI LAB LTD-ADR COMMON STOCK | $107.4M | 5.71M | 1.1% | NEW | — |
| 21 | TAYSHA GENE THERAPIES INC COMMON STOCK | $105.3M | 23.56M | 1.1% | —HELD | 0 |
| 22 | VOR BIOPHARMA INC COMMON STOCK | $96.4M | 5.40M | 1.0% | —HELD | 0 |
| 23 | GERON CORP COMMON STOCK | $95.0M | 63.77M | 1.0% | —HELD | 0 |
| 24 | ARS PHARMACEUTICALS INC COMMON STOCK | $87.2M | 10.86M | 0.9% | —HELD | 0 |
| 25 | SAREPTA THERAPEUTICS INC COMMON STOCK | $84.9M | 3.90M | 0.9% | NEW | — |
Holdings data sourced from SEC EDGAR 13F-HR filings. Updated quarterly, approximately 45 days after quarter end. All data is public domain.
Last filed: May 15, 2026